CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - April '19 update

from Stock Day Media · host Stock Day Media

CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to talk in detail about multiple wholly owned divisions, including Skyline Medical, Tumor Genesis, and Helomics. automated # breast cancer # Cytopatch # D-chip # FDA cleared # Lung cancer # medical devices # Ovvarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis # Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Apr 11, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - April '19 update

0:00 10:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 10 minutes long.

When was this Stock Day Media episode published?

This episode was published on April 11, 2019.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!